{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:55:39Z","timestamp":1790927739790,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10644-0","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:32:02Z","timestamp":1780900322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions"],"prefix":"10.1007","volume":"31","author":[{"given":"Marat","family":"Fudim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faouzi","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus E. Eduardo","family":"Rame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros G.","family":"Drakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanfear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipthi Bachamanda","family":"Somesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Zdravkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara Kova\u010devi\u0107","family":"Preradovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milosav","family":"Tomovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Kosevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"2","key":"10644_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.cardfail.2025.07.007","volume":"32","author":"Writing Committee Members","year":"2026","unstructured":"Writing Committee Members (2026) HF STATS 2025: heart failure epidemiology and outcomes statistics an updated 2025 report from the Heart Failure Society of America. J Card Fail 32(2):439\u2013498. https:\/\/doi.org\/10.1016\/j.cardfail.2025.07.007","journal-title":"J Card Fail"},{"issue":"10","key":"10644_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","volume":"29","author":"B Bozkurt","year":"2023","unstructured":"Bozkurt B, Ahmad T, Alexander KM et al (2023) Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail 29(10):1412\u20131451. https:\/\/doi.org\/10.1016\/j.cardfail.2023.07.006","journal-title":"J Card Fail"},{"key":"10644_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2026.102939","author":"SJ Greene","year":"2026","unstructured":"Greene SJ, Xu H, Chiswell K et al (2026) Residual risk despite quadruple medical therapy for men vs women hospitalized for heart failure with reduced ejection fraction. JACC Heart Fail. https:\/\/doi.org\/10.1016\/j.jchf.2026.102939","journal-title":"JACC Heart Fail"},{"key":"10644_CR4","doi-asserted-by":"publisher","unstructured":"Rasool W, Siddiqi AK, Khan LA (2025) Importance of patient-reported outcomes in cardiovascular illnesses. Glob Cardiol 3(2). https:\/\/doi.org\/10.4081\/cardio.2025.69","DOI":"10.4081\/cardio.2025.69"},{"key":"10644_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1388232","volume":"11","author":"R Mody","year":"2024","unstructured":"Mody R, Nee Sheth AB, Dash D et al (2024) Device therapies for heart failure with reduced ejection fraction: a new era. Front Cardiovasc Med 11:1388232. https:\/\/doi.org\/10.3389\/fcvm.2024.1388232","journal-title":"Front Cardiovasc Med"},{"key":"10644_CR6","doi-asserted-by":"publisher","unstructured":"Pinto FJ, Anker SD, Abraham WT et al (2025) The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide. Glob Cardiol 3(1). https:\/\/doi.org\/10.4081\/cardio.2025.68","DOI":"10.4081\/cardio.2025.68"},{"issue":"3","key":"10644_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ehf2.12169","volume":"4","author":"K Macfelda","year":"2017","unstructured":"Macfelda K, Kapeller B, Holly A et al (2017) Bioelectrical signals improve cardiac function and modify gene expression of extracellular matrix components. ESC Heart Fail 4(3):291\u2013300. https:\/\/doi.org\/10.1002\/ehf2.12169","journal-title":"ESC Heart Fail"},{"issue":"2","key":"10644_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ehf2.12080","volume":"3","author":"B Kapeller","year":"2016","unstructured":"Kapeller B, Mueller J, Losert U, Podesser BK, Macfelda K (2016) Microcurrent stimulation promotes reverse remodelling in cardiomyocytes. ESC Heart Fail 3(2):122\u2013130. https:\/\/doi.org\/10.1002\/ehf2.12080","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10644_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25063268","volume":"25","author":"D Bachamanda Somesh","year":"2024","unstructured":"Bachamanda Somesh D, J\u00fcrchott K, Giesel T et al (2024) Microcurrent-mediated modulation of myofibroblasts for cardiac repair and regeneration. Int J Mol Sci 25(6):3268. https:\/\/doi.org\/10.3390\/ijms25063268","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10644_CR10","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ehf2.13242","volume":"8","author":"D Kosevic","year":"2021","unstructured":"Kosevic D, Wiedemann D, Vukovic P et al (2021) Cardio-microcurrent device for chronic heart failure: first-in-human clinical study. ESC Heart Fail 8(2):962\u2013970. https:\/\/doi.org\/10.1002\/ehf2.13242","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10644_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000064517","volume":"39","author":"X Li","year":"2002","unstructured":"Li X, Kolega J (2002) Effects of Direct Current Electric Fields on Cell Migration and Actin Filament Distribution in Bovine Vascular Endothelial Cells. J Vasc Res 39(5):391\u2013404. https:\/\/doi.org\/10.1159\/000064517","journal-title":"J Vasc Res"},{"issue":"11","key":"10644_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/life11111195","volume":"11","author":"C Lu","year":"2021","unstructured":"Lu C, Kolbenschlag J, N\u00fcssler AK et al (2021) Direct current electrical fields improve experimental wound healing by activation of cytokine secretion and Erk1\/2 pathway stimulation. Life Basel 11(11):1195. https:\/\/doi.org\/10.3390\/life11111195","journal-title":"Life Basel"},{"issue":"2","key":"10644_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/biomedicines12020465","volume":"12","author":"DG Kiseleva","year":"2024","unstructured":"Kiseleva DG, Kirichenko TV, Markina YV, Cherednichenko VR, Gugueva EA, Markin AM (2024) Mechanisms of Myocardial Edema Development in CVD Pathophysiology. Biomedicines 12(2):465. https:\/\/doi.org\/10.3390\/biomedicines12020465","journal-title":"Biomedicines"},{"issue":"8","key":"10644_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jacbts.2023.01.008","volume":"8","author":"Z Pu","year":"2023","unstructured":"Pu Z, Shimizu Y, Hayashi T et al (2023) Cardiac lymphatic insufficiency leads to diastolic dysfunction via myocardial morphologic change. JACC Basic Transl Sci 8(8):958\u2013972. https:\/\/doi.org\/10.1016\/j.jacbts.2023.01.008","journal-title":"JACC Basic Transl Sci"},{"issue":"10","key":"10644_CR15","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ejhf.3763","volume":"27","author":"JE Rame","year":"2025","unstructured":"Rame JE, Schmitto JD, Kosevic DN et al (2025) Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: results from the C-MIC II open-label randomized controlled trial. Eur J Heart Fail 27(10):1837\u20131849. https:\/\/doi.org\/10.1002\/ejhf.3763","journal-title":"Eur J Heart Fail"},{"key":"10644_CR16","unstructured":"Berlin Heals GmbH. Pilot Study to Investigate the Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead. clinicaltrials.gov (2026) Accessed March 26, 2026. https:\/\/clinicaltrials.gov\/study\/NCT06920030"},{"issue":"5","key":"10644_CR17","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1002\/ehf2.15369","volume":"12","author":"DB Kosevic","year":"2025","unstructured":"Kosevic DB, Radak U, Vukovic P et al (2025) Two-year outcomes of a cardiac microcurrent device in chronic heart failure: a first-in-human pilot study. ESC Heart Fail 12(5):3264\u20133275. https:\/\/doi.org\/10.1002\/ehf2.15369","journal-title":"ESC Heart Fail"},{"issue":"5","key":"10644_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ejhf.1747","volume":"22","author":"I Cabac-Pogorevici","year":"2020","unstructured":"Cabac-Pogorevici I, Muk B, Rustamova Y, Kalogeropoulos A, Tzeis S, Vardas P (2020) Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology. Eur J Heart Fail 22(5):789\u2013799. https:\/\/doi.org\/10.1002\/ejhf.1747","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10644_CR19","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s11886-022-01766-6","volume":"24","author":"MG Del Buono","year":"2022","unstructured":"Del Buono MG, Moroni F, Montone RA, Azzalini L, Sanna T, Abbate A (2022) Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction. Curr Cardiol Rep 24(10):1505\u20131515. https:\/\/doi.org\/10.1007\/s11886-022-01766-6","journal-title":"Curr Cardiol Rep"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10644-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10644-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10644-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:27:56Z","timestamp":1790926076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10644-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10644"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10644-0","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Rame reports receiving consulting fees from Berlin Heals and Abbott Laboratories. Dr Fudim reports receiving consulting fees from Berlin Heals. Dr Anker reports receiving research support from Abbott Vascular and Vifor Pharma, and personal fees from Abbott Vascular, Berlin Heals, Bayer, BRAHMS, Boehringer Ingelheim, Cardiac Dimensions, Impulse Dynamics, Novartis, Servier, and Vifor Pharma. Drs Kallel and Somesh are Berlin Heals employees.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"71"}}